Showing results (151-160 of 321) with videos related to
Sort By:
Pageof 33
Journal of Cardiac Failure|July 25, 2000
What does ATLAS really tell us about "high" dose angiotensin-converting enzyme inhibition in heart failure?J M Nicklas, J N Cohn, B PittAmerican Heart Journal|July 1, 1983
The effects of bromocriptine in patients with congestive heart failureG S Francis, R Parks, J N CohnCirculation|October 1, 1977
Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failureE Mikulic, J N Cohn, J A FranciosaJournal of Pediatric Ophthalmology and Strabismus|November 1, 1987
Bradycardia with traumatic hyphema in childrenJ N Cohn, D Scagliotti, T A DeutschBritish Journal of Clinical Pharmacology|June 1, 1982
A review of the haemodynamic effects of labetalol in manJ N Cohn, J Mehta, G S FrancisCirculation|March 1, 1986
Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failureM Petein, T B Levine, J N CohnJournal of the American College of Cardiology|August 1, 1984
Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failureM Petein, T B Levine, J N CohnAnnals of Internal Medicine|April 1, 1977
Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patientsJ A Franciosa, G Pierpont, J N CohnCirculation|September 1, 1975
Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failureE Mikulic, J A Franciosa, J N CohnAngiology|March 1, 1979
Decreased venous distensibility in essential hypertension: lack of systemic hemodynamic correlatesG Simon, J A Franciosa, J N CohnPageof 33